Tuberculosis multi drug resistant active
Clinical trials for Tuberculosis multi drug resistant active explained in plain language.
Never miss a new study
Get alerted when new Tuberculosis multi drug resistant active trials appear
Sign up with your email to follow new studies for Tuberculosis multi drug resistant active, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 6-Month TB drug cocktail could replace Year-Long ordeal
Disease control Recruiting nowThis study tests a new 6-month treatment called BPaLM for people with multidrug-resistant tuberculosis (MDR-TB). The goal is to see if it works as well as the current 18+ month regimen. About 55 adults in France will receive the shorter treatment, and their outcomes will be compa…
Matched conditions: TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Smart dosing could make MDR-TB treatment safer
Disease control Recruiting nowThis study tests whether adjusting the dose of the antibiotic linezolid based on regular blood tests can reduce harmful side effects in people being treated for multidrug-resistant tuberculosis (MDR-TB). The trial will enroll 150 patients in Guinea who are on a standard 6-month r…
Matched conditions: TUBERCULOSIS MULTI DRUG RESISTANT ACTIVE
Phase 4 • Sponsor: Marco Schiuma • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC